Send to

Choose Destination
See comment in PubMed Commons below
Br J Haematol. 2006 Jan;132(2):168-70.

Lack of CD27 in myeloma delineates different presentation and outcome.

Author information

Department of Clinical Haematology, Hôtel Dieu, France.


CD27 expression was evaluated on normal plasma cells (PC), PC from patients with multiple myeloma (MM) at diagnosis or relapse and on human myeloma cell lines (HMCL). CD27 was expressed by normal PC but was lacking in PC from MM patients at diagnosis (36%) and relapse (47%), and in HMCL (92%). The prognostic impact of CD27 expression was evaluated in 42 patients with de novo MM. Overall survival was 92% at 3 years in CD27(+) vs. 50% in CD27(-) MM (P = 0.017). CD27 expression seems to delineate two important subsets of MM with different presenting features and clinical outcomes.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center